Literature DB >> 14500498

Rapid displacement of Cryptosporidium parvum type 1 by type 2 in mixed infections in piglets.

Donna E Akiyoshi1, Siobhan Mor, Saul Tzipori.   

Abstract

Genotypes 1 and 2 of Cryptosporidium parvum are the primary types associated with infections in humans, with type 1 being by far the predominant genotype. The frequency of mixed infection with both genotypes in humans is relatively rare, while type 1, which experimentally infects other mammals, has been found to naturally infect almost exclusively humans. One possible explanation for the absence of type 1 in other mammals and the low frequency of mixed infections in humans is the inability of type 1 to compete with type 2 in nature when both occur simultaneously. To investigate this, we challenged gnotobiotic piglets with equal number of oocysts of type 1 and type 2, given either simultaneously or with type 2 given 24 or 48 h after type 1. The genotype of the oocysts excreted in feces and the relative distribution of each of the genotypes throughout the gut at necropsy were determined. Regardless of the time interval between challenges with the two genotypes, type 2 invariably displaced type 1. The rate of displacement was rapid when both genotypes were given simultaneously, after which no traces of type 1 were detected in the feces or in gut sections by PCR. Infection with type 1 24 or 48 h before challenge with type 2, while permitting type 1 to become established, was still rapidly eliminated within 3 days after challenge with type 2. These observations have major implications regarding the relative perpetuation and survival of these two genotypes in mammals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500498      PMCID: PMC201101          DOI: 10.1128/IAI.71.10.5765-5771.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Cryptosporidiosis: biology, pathogenesis and disease.

Authors:  Saul Tzipori; Honorine Ward
Journal:  Microbes Infect       Date:  2002-08       Impact factor: 2.700

2.  Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice.

Authors:  Pablo C Okhuysen; Stephen M Rich; Cynthia L Chappell; Kevin A Grimes; Giovanni Widmer; Xiaochuan Feng; Saul Tzipori
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

3.  Genetic characterization of Cryptosporidium strains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis.

Authors:  J McLauchlin; S Pedraza-Díaz; C Amar-Hoetzeneder; G L Nichols
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

4.  Three drinking-water-associated cryptosporidiosis outbreaks, Northern Ireland.

Authors:  Scott Glaberman; John E Moore; Colm J Lowery; Rachel M Chalmers; Irshad Sulaiman; Kristin Elwin; Paul J Rooney; Beverley C Millar; James S G Dooley; Altaf A Lal; Lihua Xiao
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

5.  Cryptosporidium dose-response studies: variation between hosts.

Authors:  Peter F M Teunis; Cynthia L Chappell; Pablo C Okhuysen
Journal:  Risk Anal       Date:  2002-06       Impact factor: 4.000

6.  Identification of the cryptosporidium pig genotype in a human patient.

Authors:  Lihua Xiao; Caryn Bern; Michael Arrowood; Irshad Sulaiman; Ling Zhou; Vivian Kawai; Aldo Vivar; Altaf A Lal; Robert H Gilman
Journal:  J Infect Dis       Date:  2002-06-15       Impact factor: 5.226

Review 7.  Recent advances in cryptosporidiosis: the immune response.

Authors:  Michael W Riggs
Journal:  Microbes Infect       Date:  2002-08       Impact factor: 2.700

Review 8.  Cryptosporidiosis: epidemiology and impact.

Authors:  Rebecca A Dillingham; Aldo A Lima; Richard L Guerrant
Journal:  Microbes Infect       Date:  2002-08       Impact factor: 2.700

9.  Analysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa.

Authors:  Brett A Leav; Malanie R Mackay; Akudo Anyanwu; Roberta M O' Connor; Ana Maria Cevallos; Gurpreet Kindra; Nigel C Rollins; Michael L Bennish; Richard G Nelson; Honorine D Ward
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Cryptosporidium oocysts in a water supply associated with a cryptosporidiosis outbreak.

Authors:  Andrew D Howe; Sue Forster; Stephen Morton; Roberta Marshall; Keith S Osborn; Peter Wright; Paul R Hunter
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

View more
  11 in total

1.  Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum.

Authors:  Abhineet Sheoran; Anthony Wiffin; Giovanni Widmer; Pradeep Singh; Saul Tzipori
Journal:  J Infect Dis       Date:  2012-01-25       Impact factor: 5.226

2.  Coevolution of Cryptosporidium tyzzeri and the house mouse (Mus musculus).

Authors:  Martin Kváč; John McEvoy; Martina Loudová; Brianna Stenger; Bohumil Sak; Dana Květoňová; Oleg Ditrich; Veronika Rašková; Elaine Moriarty; Michael Rost; Miloš Macholán; Jaroslav Piálek
Journal:  Int J Parasitol       Date:  2013-06-18       Impact factor: 3.981

3.  Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils.

Authors:  Asiya Baishanbo; Gilles Gargala; Agnès Delaunay; Arnaud François; Jean-Jacques Ballet; Loïc Favennec
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Detection of Cryptosporidium parvum and Cryptosporidium hominis in human patients in Cairo, Egypt.

Authors:  Nour M Abd El Kader; María-Alejandra Blanco; Marwa Ali-Tammam; Abd El Rahman B Abd El Ghaffar; Ahmed Osman; Nabila El Sheikh; José Miguel Rubio; Isabel de Fuentes
Journal:  Parasitol Res       Date:  2011-05-24       Impact factor: 2.289

5.  Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission.

Authors:  Siobhan M Mor; James K Tumwine; Grace Ndeezi; Maheswari G Srinivasan; Deogratias H Kaddu-Mulindwa; Saul Tzipori; Jeffrey K Griffiths
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

6.  Terminal restriction fragment length polymorphism for identification of Cryptosporidium species in human feces.

Authors:  L S Waldron; B C Ferrari; M R Gillings; M L Power
Journal:  Appl Environ Microbiol       Date:  2008-10-31       Impact factor: 4.792

Review 7.  Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge.

Authors:  Siobhan M Mor; Saul Tzipori
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

8.  Individual subject meta-analysis of parameters for Cryptosporidium parvum shedding and diarrhoea in animal experimental models.

Authors:  A D Adell; W A Miller; D J Harvey; E Vanwormer; S Wuertz; P A Conrad
Journal:  Epidemiol Infect       Date:  2012-10-16       Impact factor: 4.434

9.  Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.

Authors:  Karine Thivierge; Sophie Cotton; Deborah A Schaefer; Michael W Riggs; Joyce To; Maria E Lund; Mark W Robinson; John P Dalton; Sheila M Donnelly
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

10.  A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.

Authors:  R S Jumani; K Bessoff; M S Love; P Miller; E E Stebbins; J E Teixeira; M A Campbell; M J Meyers; J A Zambriski; V Nunez; A K Woods; C W McNamara; C D Huston
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.